GPT and macrophage activation syndrome: Similarly, in several retrospective studies, patients with MAS treated with high-dose corticosteroids, cyclosporine, anakinra, or ruxolitinib showed improvements in laboratory parameters such as ALT, AST, and normalization of clinical signs, indicating MAS remission (21–24).